Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 999, pseudogene (RNU6-999P) is a processed pseudogene related to U6 small nuclear RNA genes. While functional U6 snRNAs are integral non-coding RNAs essential for splicing of pre-mRNA as part of the spliceosome[1][3], U6-derived pseudogenes do not encode functional RNA products and are not directly involved in RNA splicing. Instead, like other pseudogenes, RNU6-999P may be transcribed without producing functional protein or RNA, and could potentially have regulatory roles, such as acting as a miRNA "decoy" or generating endogenous siRNAs[6][8]. However, there is no direct evidence that RNU6-999P itself has a specific biological or disease function, nor is it a therapeutic target or druggable molecule[5]. Key clarifications: - RNU6-999P is not a protein, receptor, enzyme, or transporter. - It is not a therapeutic target and does not have associated drugs or mechanisms of action. - There is no evidence of biomarker utility, safety concerns, or direct disease relevance. - The entry is "incorrect" as a canonical drug target due to its classification as a pseudogene and lack of direct functional or therapeutic relevance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 999, pseudogene (RNU6-999P).